Citius Pharmaceuticals Statistics
Total Valuation
CTXR has a market cap or net worth of $92.52 million. The enterprise value is $80.30 million.
Market Cap | 92.52M |
Enterprise Value | 80.30M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
Earnings Date | Aug 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CTXR has 180.67 million shares outstanding. The number of shares has increased by 8.77% in one year.
Shares Outstanding | 180.67M |
Shares Change (YoY) | +8.77% |
Shares Change (QoQ) | +0.07% |
Owned by Insiders (%) | 6.81% |
Owned by Institutions (%) | 15.09% |
Float | 168.36M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 1.29 |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.17 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.17, with a Debt / Equity ratio of 0.00.
Current Ratio | 5.17 |
Quick Ratio | n/a |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -42.40% and return on invested capital (ROIC) is -49.04%.
Return on Equity (ROE) | -42.40% |
Return on Assets (ROA) | -37.20% |
Return on Capital (ROIC) | -49.04% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.70M |
Employee Count | 22 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CTXR has paid $576,000 in taxes.
Income Tax | 576,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.03% in the last 52 weeks. The beta is 1.62, so CTXR's price volatility has been higher than the market average.
Beta (5Y) | 1.62 |
52-Week Price Change | -59.03% |
50-Day Moving Average | 0.66 |
200-Day Moving Average | 0.73 |
Relative Strength Index (RSI) | 33.42 |
Average Volume (20 Days) | 1,967,255 |
Short Selling Information
The latest short interest is 15.46 million, so 8.56% of the outstanding shares have been sold short.
Short Interest | 15.46M |
Short Previous Month | 15.91M |
Short % of Shares Out | 8.56% |
Short % of Float | 9.18% |
Short Ratio (days to cover) | 7.22 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -39.11M |
Pretax Income | -35.62M |
Net Income | -37.35M |
EBITDA | -35.42M |
EBIT | -35.62M |
Earnings Per Share (EPS) | -$0.24 |
Balance Sheet
The company has $12.60 million in cash and $374,831 in debt, giving a net cash position of $12.22 million or $0.07 per share.
Cash & Cash Equivalents | 12.60M |
Total Debt | 374,831 |
Net Cash | 12.22M |
Net Cash Per Share | $0.07 |
Equity (Book Value) | 79.37M |
Book Value Per Share | 0.44 |
Working Capital | 17.40M |
Cash Flow
Operating Cash Flow | -30.30M |
Capital Expenditures | n/a |
Free Cash Flow | -30.30M |
FCF Per Share | -$0.19 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CTXR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -8.77% |
Shareholder Yield | -8.77% |
Earnings Yield | -40.37% |
FCF Yield | -32.75% |
Analyst Forecast
The average price target for CTXR is $4.00, which is 681.10% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.00 |
Price Target Difference | 681.10% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 9, 2017. It was a reverse split with a ratio of 1:15.
Last Split Date | Jun 9, 2017 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |